Patient INformation About Options for Treatment - PINOT
PINOT
Patient Information About Options for Treatment of Stage 5 Chronic Kidney Disease
1 other identifier
observational
721
1 country
1
Brief Summary
This prospective observational study is designed to find out what treatment options new patients with chronic kidney disease learn about from their renal unit. Aims: To determine the proportion of new CKD patients who receive information about treatment options prior to commencing dialysis, pre-emptive transplantation or conservative management. To determine the timing (i.e. patient's stage of disease) when information is given. To find out whether patients have a friend or family member with them when information is given. Research Design and methods: This study is an assessment of CKD education practices. Nephrologists and pre-dialysis coordinators from each renal unit will complete questionnaires about information that was given to each new dialysis, pre-emptive transplant or conservatively managed patient that started treatment during a 3 month period. Study hypothesis: Approximately one third of CKD patients will receive information after starting treatment. There will be a positive association between in-centre haemodialysis and later referral, non-English speaking background, and advancing age. Significance: The results from this national audit will provide Australian nephrologists and renal nurses with evidence about CKD education practices and compliance with clinical practice guidelines. The results may highlight opportunities for improvement in practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 15, 2011
CompletedFirst Posted
Study publicly available on registry
February 17, 2011
CompletedFebruary 17, 2011
February 1, 2011
5 months
February 15, 2011
February 15, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of incident Stage 5 CKD patients who receive information about their treatment options prior to commencing treatment
Time prior to commencement of treatment. eg. 3 months
Secondary Outcomes (2)
Stage of CKD (based on eGFR) when information about treatment options is first given
one time point prior to commencement of treatment
Patient and unit characteristics associated with commencing renal replacement therapy versus conservative care
One time point based on commencement date of first treatment
Study Arms (1)
Stage 5 chronic kidney disease
Incident patients commencing renal replacement therapy or conservative care
Eligibility Criteria
Adults and children with chronic kidney disease attending renal treatment centres in Australian public hospitals and private practices.
You may qualify if:
- Patients attending Australian adult or pediatric renal units
- Patients with Stage 5 chronic kidney disease commencing dialysis or having a pre-emptive transplant or with decision made for conservative care and eGFR \< 15ml/min/1.73m2 between 1st July and 30th September 2009
You may not qualify if:
- Patients with acute kidney injury not requiring chronic renal replacement therapy
- Patients with a failing kidney transplant returning to dialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sydneylead
- National Health and Medical Research Council, Australiacollaborator
- Sydney South West Area Health Servicecollaborator
- South West Sydney Local Health Districtcollaborator
Study Sites (1)
University of Sydney
Sydney, New South Wales, 2006, Australia
Related Publications (2)
Morton RL, Howard K, Webster AC, Snelling P. Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease. Nephrology (Carlton). 2010 Sep;15(6):649-52. doi: 10.1111/j.1440-1797.2010.01340.x.
PMID: 20931747BACKGROUNDMorton RL, Howard K, Webster AC, Snelling P. Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrol Dial Transplant. 2011 Apr;26(4):1266-74. doi: 10.1093/ndt/gfq555. Epub 2010 Sep 6.
PMID: 20819955RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kirsten Howard, PhD
University of Sydney
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 15, 2011
First Posted
February 17, 2011
Study Start
July 1, 2009
Primary Completion
December 1, 2009
Study Completion
December 1, 2010
Last Updated
February 17, 2011
Record last verified: 2011-02